Which has grown faster, AQST or CRMD?

Over the past five years, CRMD grew revenue faster — AQST at a -0.58% CAGR versus CRMD at 352.03%.

Is AQST or CRMD more profitable?

CRMD runs the higher net margin — AQST at -144.63% versus CRMD at 40.49%.

How have AQST and CRMD total returns compared?

Over the past 5 years, AQST delivered 2.24% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.

Aquestive Therapeutics, Inc. (AQST) vs CorMedix Inc. (CRMD)

A side-by-side comparison of Aquestive Therapeutics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AQST

Aquestive Therapeutics, Inc.

$565M

$4.51HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

CRMD

CorMedix Inc.

$562M

$7.17HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

Total return — AQST vs CRMD

growth of $100 · dividends reinvested · last 8y

AQST -71.5% (-14.5%/yr)CRMD +437.8% (+23.4%/yr)CRMD compounded faster over this window

Log scale — wide-divergence pair

AQST CRMD

AQST vs CRMD: by the numbers

•AQST is the larger company ($565M vs $562M market cap).
•CRMD is profitable (40.49% net margin) while AQST runs a net loss (-144.63%).
•CRMD grew revenue faster over the past five years (352.03% vs -0.58% CAGR).

Metrics side by side

Valuation

Metric	AQST	CRMD
P/E ratio	N/A	3.37
Forward P/E	N/A	14.48
P/S ratio	10.45	1.22
P/B ratio	N/A	1.22
EV / EBITDA	N/A	1.79
FCF yield	N/A	44.50%

Profitability

Metric	AQST	CRMD
Gross margin	67.04%	82.78%
Operating margin	-156.36%	46.95%
Net margin	-144.63%	40.49%
ROE	N/A	40.62%
ROIC	-45.62%	27.87%

Growth (annualized)

Metric	AQST	CRMD
Revenue CAGR (5Y)	-0.58%	352.03%
Total return CAGR (5Y)	2.24%	9.70%

Frequently asked

Which has grown faster, AQST or CRMD?: Over the past five years, CRMD grew revenue faster — AQST at a -0.58% CAGR versus CRMD at 352.03%.
Is AQST or CRMD more profitable?: CRMD runs the higher net margin — AQST at -144.63% versus CRMD at 40.49%.
How have AQST and CRMD total returns compared?: Over the past 5 years, AQST delivered 2.24% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AQST analysis Full CRMD analysis Interactive comparison tool

Dig into the metrics

CorMedix P/E ratio Aquestive Therapeutics ROE CorMedix ROE Aquestive Therapeutics operating margin CorMedix operating margin Aquestive Therapeutics revenue growth CorMedix revenue growth Aquestive Therapeutics free cash flow CorMedix free cash flow

Aquestive Therapeutics & CorMedix appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.